ATTENTION BIOTECHIES: I assume, despite the less than stellar performance of most Contest portfolios in 2016, there’s still interest in a 2017 Biotech Charity Contest. Please let me know if my assumption is correct. Thanks, Bulba.
12/2/16 Contest update
The Price is not right! That’s what it seems, judging by the performance of biotech stocks following Trump’s selection of Dr. Tom Price, a strident opponent of Obamacare, as his secretary of health & human services. Here’s Ars Technica on Price:
“[Price] opposes abortion rights and regulations on tobacco, for instance. But he also belongs to a small, fringe, ultra-conservative and conspiracy-laden group called the Association of American Physicians and Surgeons (AAPS). Among other things, this group decries evidence-based medicine, Medicare, and Medicaid, plus it has peddled discredited, dangerous notions including that vaccines cause autism.”
arstechnica.com
Meanwhile, at Friday’s close, the Contest median was down -25.11% YTD (vs. down -20.45% YTD a week ago). The Nasdaq Biotech Index (NBI) was down -20.07% YTD (vs. down -15.86% YTD a week ago), while the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was down -11.98% YTD (vs. down -5.45% YTD a week ago). The Nasdaq Composite Index (NCI) was up 4.96% YTD (vs. up 7.82% YTD a week ago).
JBOG’s portfolio, up 26.48% YTD, remained in first place, with DNAJOE’s portfolio, up 20.16% YTD, and STEVEL’s portfolio, up 15.77% YTD, still in second place & third place.
At Friday’s close, 6 of the 58 Contest portfolios were in the green, with 23 portfolios beating the NBI and 14 beating the SPSIBI. The 223 Contest stock picks had an average YTD loss of -18.14% and a median YTD loss of -30.69%, with 54 of the 223 Contest portfolio stocks up for the year.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week, ranked by % Gained and % Lost. (Prices not converted to US$ in these Tables.)
Portfolio adjustments:
1) CASC did 1-6 reverse split.
2) GNVC did 1-10 reverse split.
3) AEGR merger with QLTI. AEGR received 1.0256 shares of QLTI which changed its name & symbol to Novelion & NVLN. Three Contest portfolios held AEGR; BIOADD, GHMM, WATCHIT.
(All corrections, especially adjustments for splits, greatly appreciated.)
Have a wonderful winter weekend biotechies.
Peace & good health,
Bulba
12/2/16
Rank Name Profit/Loss
1 JBOG 26,482
2 DNAJOE 20,157
3 STEVEL 15,769
4 BIOPLAY 15,266
5 BMAZ 5,168
6 USUBAN 727
7 THEOX -1,461
8 CEMBP -2,810
9 GHMM -4,100
10 TOMP -6,988
Week's Top 5 Gainers
Symbol 11/25/16 12/2/16 Wk.%chg.
APPY 2.80 4.05 44.64%
EPIX 1.88 2.34 24.70%
GBIM 0.47 0.57 21.41%
NVET 4.12 4.94 19.88%
ICCC 5.35 6.30 17.76%
Week's Worst 5 Losers
Symbol 11/25/16 12/2/16 Wk.%chg.
ARWR 4.67 1.44 -69.16%
ARDM 5.31 2.17 -59.13%
PLX 0.51 0.31 -39.22%
TVIA 1.700 1.150 -32.35%
BPMC 37.47 27.01 -27.92%
|
